ArticleJournal of oncology2023

IDO1 Activity Predicts Lung Toxicity in Patients with Unresectable Stage III NSCLC and Chemoradiotherapy.

Linfang Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.